Chapter 14 Elucidation of Chemerin and Chemokine-Like Receptor-1 Function in Adipocytes by Adenoviral-Mediated shRNA Knockdown of Gene Expression

Methods in Enzymology

Volumn 460, Issue A, 2009, Pages 289-312

  Goralski, Kerry B ^a,b   Sinal, Christopher J ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ADIPOCYTOKINE; CHEMERIN; CHEMOKINE RECEPTOR; GLUCOSE; PROTEIN DERIVATIVE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; CHEMERIN PROTEIN, MOUSE; CHEMOTACTIC FACTOR; CMKLR1 PROTEIN, MOUSE; G PROTEIN COUPLED RECEPTOR; SIGNAL PEPTIDE; SMALL INTERFERING RNA;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; AUTOCRINE EFFECT; BLOOD PRESSURE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DENDRITIC CELL; ENERGY BALANCE; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; IMMUNE SYSTEM; LIPID METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; RNA ISOLATION; SIGNAL TRANSDUCTION; VIRUS TITRATION; ADENOVIRUS; ANIMAL; ARTICLE; CYTOLOGY; GENE SILENCING; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

3T3-L1 CELLS; ADENOVIRIDAE; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CHEMOTACTIC FACTORS; GENE KNOCKDOWN TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING;

EID: 65549162194     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)05214-8     Document Type: Review

References (54)

1. Anthonsen M.W., Ronnstrand L., Wernstedt C., Degerman E., and Holm C. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J. Biol. Chem. 273 (1998) 215-221
2. Bozaoglu K., Bolton K., McMillan J., Zimmet P., Jowett J., Collier G., Walder K., and Segal D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148 (2007) 4687-4694
3. Carmen G.Y., and Victor S.M. Signalling mechanisms regulating lipolysis. Cell. Signal 18 (2006) 401-408
4. Dandona P., Weinstock R., Thusu K., Abdel-Rahman E., Aljada A., and Wadden T. Tumor necrosis factor-alpha in sera of obese patients: Fall with weight loss. J. Clin. Endocrinol. Metab. 83 (1998) 2907-2910
5. Darling A.J., Boose J.A., and Spaltro J. Virus assay methods: Accuracy and validation. Biologicals 26 (1998) 105-110
6. Fajas L. Adipogenesis: A cross-talk between cell proliferation and cell differentiation. Ann. Med. 35 (2003) 79-85
7. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115 (2005) 911-919 quiz 920
8. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
9. Folsom A.R., Qamhieh H.T., Wing R.R., Jeffery R.W., Stinson V.L., Kuller L.H., and Wu K.K. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb 13 (1993) 162-169
10. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
11. Garton A.J., Campbell D.G., Cohen P., and Yeaman S.J. Primary structure of the site on bovine hormone-sensitive lipase phosphorylated by cyclic AMP-dependent protein kinase. FEBS Lett. 229 (1988) 68-72
12. Goralski K.B., Acott P.D., Fraser A.D., Worth D., and Sinal C.J. Brain cyclosporin a levels are determined by ontogenic regulation of mdr1a expression. Drug Metab. Dispos. 34 (2006) 288-295
13. Goralski K.B., McCarthy T.C., Hanniman E.A., Zabel B.A., Butcher E.C., Parlee S.D., Muruganandan S., and Sinal C.J. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 282 (2007) 28175-28188
14. Goralski K.B., and Sinal C.J. Type 2 diabetes and cardiovascular disease: Getting to the fat of the matter. Can. J. Physiol. Pharmacol. 85 (2007) 113-132
15. Havel P.J. Update on adipocyte hormones: Regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53 Suppl 1 (2004) S143-S151
16. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
17. Itoh K., Imai K., Masuda T., Abe S., Tanaka M., Koga R., Itoh H., Matsuyama T., and Nakamura M. Relationship between changes in serum leptin levels and blood pressure after weight loss. Hypertens. Res. 25 (2002) 881-886
18. Karber G. Screening methods in pharmacology. Arch. Exp. Pathol. and Pharmacol. 162 (1931) 480-483
19. Kim J.B., and Spiegelman B.M. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 10 (1996) 1096-1107
20. Kim J.B., Wright H.M., Wright M., and Spiegelman B.M. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc. Natl. Acad. Sci. USA 95 (1998) 4333-4337
21. Lagace D.C., McLeod R.S., and Nachtigal M.W. Valproic acid inhibits leptin secretion and reduces leptin messenger ribonucleic acid levels in adipocytes. Endocrinology 145 (2004) 5493-5503
22. Lagace D.C., and Nachtigal M.W. Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis. J. Biol. Chem. 279 (2004) 18851-18860
23. Large V., Peroni O., Letexier D., Ray H., and Beylot M. Metabolism of lipids in human white adipocyte. Diabetes Metab. 30 (2004) 294-309
24. Leung R.K., and Whittaker P.A. RNA interference: From gene silencing to gene-specific therapeutics. Pharmacol. Ther. 107 (2005) 222-239
25. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
26. MacDougald O.A., and Mandrup S. Adipogenesis: Forces that tip the scales. Trends Endocrinol. Metab. 13 (2002) 5-11
27. Meder W., Wendland M., Busmann A., Kutzleb C., Spodsberg N., John H., Richter R., Schleuder D., Meyer M., and Forssmann W.G. Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett. 555 (2003) 495-499
28. Methner A., Hermey G., Schinke B., and Hermans-Borgmeyer I. A novel G protein-coupled receptor with homology to neuropeptide and chemoattractant receptors expressed during bone development. Biochem. Biophys. Res. Commun. 233 (1997) 336-342
29. Moretta A., Marcenaro E., Parolini S., Ferlazzo G., and Moretta L. NK cells at the interface between innate and adaptive immunity. Cell. Death Differ. 15 (2008) 226-233
30. Nagpal S., Patel S., Jacobe H., DiSepio D., Ghosn C., Malhotra M., Teng M., Duvic M., and Chandraratna R.A. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J. Invest. Dermatol. 109 (1997) 91-95
31. Orlicky D.J., and Schaack J. Adenovirus transduction of 3T3-L1 cells. J. Lipid Res. 42 (2001) 460-466
32. Parolini S., Santoro A., Marcenaro E., Luini W., Massardi L., Facchetti F., Communi D., Parmentier M., Majorana A., Sironi M., Tabellini G., Moretta A., et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109 (2007) 3625-3632
33. Primrose J.N., Davies J.A., Prentice C.R., Hughes R., and Johnston D. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb Haemost 68 (1992) 396-399
34. Roh S.G., Song S.H., Choi K.C., Katoh K., Wittamer V., Parmentier M., and Sasaki S. Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochem. Biophys. Res. Commun. 362 (2007) 1013-1018
35. Rosen E.D. The transcriptional basis of adipocyte development. Prostaglandins Leukot Essent. Fatty Acids 73 (2005) 31-34
36. Rosen E.D., Walkey C.J., Puigserver P., and Spiegelman B.M. Transcriptional regulation of adipogenesis. Genes Dev. 14 (2000) 1293-1307
37. Samad F., Pandey M., and Loskutoff D.J. Tissue factor gene expression in the adipose tissues of obese mice. Proc. Natl. Acad. Sci. USA 95 (1998) 7591-7596
38. Samad F., Yamamoto K., Pandey M., and Loskutoff D.J. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol. Med. 3 (1997) 37-48
39. Samson M., Edinger A.L., Stordeur P., Rucker J., Verhasselt V., Sharron M., Govaerts C., Mollereau C., Vassart G., Doms R.W., and Parmentier M. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur. J. Immunol. 28 (1998) 1689-1700
40. Takahashi M., Takahashi Y., Takahashi K., Zolotaryov F.N., Hong K.S., Kitazawa R., Iida K., Okimura Y., Kaji H., Kitazawa S., Kasuga M., and Chihara K. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. 582 (2008) 573-578
41. Vermi W., Riboldi E., Wittamer V., Gentili F., Luini W., Marrelli S., Vecchi A., Franssen J.D., Communi D., Massardi L., Sironi M., Mantovani A., et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201 (2005) 509-515
42. Wang M.Y., Orci L., Ravazzola M., and Unger R.H. Fat storage in adipocytes requires inactivation of leptin's paracrine activity: Implications for treatment of human obesity. Proc. Natl. Acad. Sci. USA 102 (2005) 18011-18016
43. Warne J.P. Tumour necrosis factor alpha: A key regulator of adipose tissue mass. J. Endocrinol. 177 (2003) 351-355
44. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 115 (2005) 1111-1119
45. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., and Prins J.B. Adiponectin-a key adipokine in the metabolic syndrome. Diabetes Obes Metab. 8 (2006) 264-280
46. Wittamer V., Franssen J.D., Vulcano M., Mirjolet J.F., Le Poul E., Migeotte I., Brezillon S., Tyldesley R., Blanpain C., Detheux M., Mantovani A., Sozzani S., et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 198 (2003) 977-985
47. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
48. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8 (2002) 1288-1295
49. Yu Y.H., and Ginsberg H.N. The role of acyl-CoA:diacylglycerol acyltransferase (DGAT) in energy metabolism. Ann. Med. 36 (2004) 252-261
50. Yu Y.H., and Zhu H. Chronological changes in metabolism and functions of cultured adipocytes: A hypothesis for cell aging in mature adipocytes. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E402-E410
51. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 19 (1999) 972-978
52. Zabel B.A., Zuniga L., Ohyama T., Allen S.J., Cichy J., Handel T.M., and Butcher E.C. Chemoattractants, extracellular proteases, and the integrated host defense response. Exp. Hematol. 34 (2006) 1021-1032
53. Zhang B., Graziano M.P., Doebber T.W., Leibowitz M.D., White-Carrington S., Szalkowski D.M., Hey P.J., Wu M., Cullinan C.A., Bailey P., Lollmann B., Frederich R., et al. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J. Biol. Chem. 271 (1996) 9455-9459
54. Ziccardi P., Nappo F., Giugliano G., Esposito K., Marfella R., Cioffi M., D'Andrea F., Molinari A.M., and Giugliano D. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105 (2002) 804-809